Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to grow due to the rise in the prevalence of diseases, the increase in the adoption of combination therapies, the surge in the funding for new therapies, and the approval of innovative therapies. Numerous opportunities within the realm of immune therapies exist, considering the increasing prevalence of several diseases. Moreover, there is a notable upswing in funding for developing innovative therapies and a rising trend in novel immunotherapies approval.
Emergence of Novel Immune-Mediated Therapies
AI
Share
Related Ins(AI)ghts
Related Tags
About SG Analytics
SG Analytics (SGA) is a leading global data and AI consulting firm delivering solutions across AI, Data, Technology, and Research. With deep expertise in BFSI, Capital Markets, TMT (Technology, Media & Telecom), and other emerging industries, SGA empowers clients with Ins(AI)ghts for Business Success through data-driven transformation.
A Great Place to Work® certified company, SGA has a team of over 1,600 professionals across the U.S.A, U.K, Switzerland, Poland, and India. Recognized by Gartner, Everest Group, ISG, and featured in the Deloitte Technology Fast 50 India 2024 and Financial Times & Statista APAC 2025 High Growth Companies, SGA delivers lasting impact at the intersection of data and innovation.